Упрощенная HTML-версия
215.
Naoumov N.V. Studies of interleukin-12 in chronic hepatitis B virus infection /
N.V. Naoumov, S. Rossol // J. Viral. Hepat. - 1997. - Suppl 2. - P. 87-91.
216.
NKT cells: Facts, functions and fallacies / D.J. Godfrey, K.J. Hammond L.D.
Poulon et al. // Imunol. Today. - 2000. - Vol.
21. - P.
573-583.
217.
Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor
alpha-stimulated nuclear factor kappa B activation / K.J. Park, S.H. Choi, S.Y.
Lee et al. // J. Biol. Chem. - 2002. - Vol.277,№15. – Р. 13122-13128.
218.
Okaya T. Cytokine cascades and the hepatic inflammatory response to
ischemia and reperfusion / T. Okaya, A.B. Lentsch // J. Invest. Surg. - 2003. -
Vol.16,№3. -Р. 141-147.
219.
Pathophysiological roles of interleukin-18 in inflammatory liver diseases / H.
Tsutsui, K. Matsui, H. Okamura, K. Nakanishi // Immunol. Rev. - 2000. -
Vol.174. - P. 192-209.
220.
Phenotypic and functional characterization of
in
trahepatic natural killer and
macrophages
in
viral chronic
hepatitis
C (VCH) / C. Garcia-Monzon, L. Garcia-
Bluey, M.J. Borque et al. // Hepatology. - 1995. -Vol.22. –P. 337.
221.
Plasma transforming growth factor-beta 1 concentrations in patients with
chronic viral hepatitis / Y. Murawaki, Y. Nishimura, Y. Ikuta et al. // J.
Gastroenterol. Hepatol. - 1998. - Vol.13,№7. - Р. 680-684.
222.
Polymorphisms in tumour necrosis factor alpha, interleukin-10 and
transforming growth factor beta1 genes and end-stage liver disease / A.J.
Bathgate, V. Pravica, C. Perrey et al. // Eur. J. Gastroenterol. Hepatol. - 2000. -
Vol.12,№12. - Р. 1329-1333.
223.
Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-
beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C